Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?
NCT00205166 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2012-10-29
Summary
We are studying the affect of caffeine on the sensitivity of detecting coronary artery disease (blockages in the blood flow to the heart) with adenosine tracer scans. Adenosine is a drug used routinely in patients to relax heart blood vessels in order to assess for the presence of coronary artery disease. Often, if patients have had caffeine, the adenosine scan is not used because of the belief that caffeine may reduce the ability to detect coronary artery disease. We would like to test whether caffeine affects our ability to detect coronary artery disease with adenosine tracer scanning. We will perform an imaging study of the heart with adenosine after you have received caffeine.
Conditions
Interventions
- PROCEDURE
-
Cardiac SPECT imaging Rest and Stress
adenosine perfusion scintigraphy
- DRUG
-
Caffeine
Caffeine 400 mg po
- DRUG
-
Caffeine
Caffeine 200 mg po
Sponsors & Collaborators
-
Astellas Pharma US, Inc.
collaborator INDUSTRY -
University of Wisconsin, Madison
lead OTHER
Principal Investigators
-
Charles K Stone, MD · Univeristy of Wisconsin
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-06-30
- Primary Completion
- 2004-12-31
- Completion
- 2004-12-31
Countries
- United States
Study Locations
More Related Trials
-
Adenosine Receptors Influence Ischemia-Reperfusion Injury
NCT00184847 ·Status: SUSPENDED ·Phase: NA
-
Effect of Polymorphisms in the Adenosine a2a Receptor Gene and AMPD2 Gene on Adenosine-Induced Vasodilation and Reactive Hyperemia
NCT00253929 ·Status: COMPLETED ·Phase: NA
-
Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor
NCT02311088 ·Status: TERMINATED ·Phase: PHASE2
-
Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?
NCT00457652 ·Status: COMPLETED ·Phase: PHASE4
-
Caffeine and Cerebrovascular Reactivity
NCT04730193 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Role of Adenosine in the Release of VEGF and Cytokines
NCT00580905 ·Status: TERMINATED ·Phase: PHASE1
-
Clinical Trial on the Effects of Caffeine and Taurine From Energy Drinks (EDs) to Parameters of the Cardiovascular System in Humans
NCT01421979 ·Status: COMPLETED ·Phase: NA
-
The Effect of Caffeine in Elderly Citizen Following Eight Hour Abstinence From Caffeine Containing Drinks & Foods
NCT01048515 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Antioxidant Agents on the Number of DNA Double-strand Breaks After Radiation-based Cardiac Examinations
NCT01578395 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Reperfusion Event by Vitamin C Infusion
NCT01090895 ·Status: UNKNOWN ·Phase: PHASE4
-
Exploratory Study Using Positron Emission Tomography With TS-121 and [11C]TASP0410699 in Healthy Adult Male Subjects
NCT02448212 ·Status: COMPLETED ·Phase: PHASE1
-
Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate
NCT02135965 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of Caffeine Consumption on Protein Biomarkers and Cardiovascular Disease
NCT06359197 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Acute Caffeine Effects on Cardiac Autonomic and Cardiorespiratory Parameters Responses After Aerobic Exercise
NCT02917889 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Phenylephrine and Ephedrine on Microvascular Blood Flow
NCT02252627 ·Status: UNKNOWN
-
Acute Effects of PLT Health Solutions zümXR Extended-Release Caffeine
NCT06441695 ·Status: COMPLETED ·Phase: NA
-
The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in Humans
NCT00184886 ·Status: COMPLETED ·Phase: NA
-
Nitrate Supplementation on Motor Unit Activity
NCT05993715 ·Status: COMPLETED ·Phase: NA
-
Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity
NCT06978777 ·Status: RECRUITING ·Phase: NA
-
Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose in Healthy Male Subjects
NCT02259985 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Chronic and Acute Caffeine Intake on the Hematopoietic System
NCT07193264 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Activation of Cervical and Upper Thoracic Brown Adipose Tissue in Humans Via Beta-adrenergic Stimulation
NCT01015794 ·Status: COMPLETED ·Phase: NA
-
Consequences of Caffeine Intake in Sleep Restricted Teenagers
NCT05790161 ·Status: UNKNOWN ·Phase: NA
-
Creatine Monohydrate Use for Preventing Altitude Induced Depression
NCT03433651 ·Status: WITHDRAWN ·Phase: PHASE4
-
Caffeine Disposition After Inhalation
NCT02184104 ·Status: COMPLETED ·Phase: NA